Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKCAP: Aspirin and/or Folate for Colorectal Adenoma Prevention
NCT00033319Phase 3Unknown
- Sponsor
- The Queen's Medical Center
- Start
- May 1997
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin and folic acid in Colorectal Adenoma (CRA) (4 arms), sponsored by The Queen's Medical Center. Primary endpoint: Recurrence of colorectal adenomas at 3 years. Status: unknown.
02
Drugs
aspirinfolic acid
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT00033319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033319.